ABSTRACT
Objective To discuss the effect of sIL-1RI on allograft survival after islet transplantation.Methods Islets were isolated and transfected with Ad-sIL-1RI-Ig.Mice were treated with STZ to induce insulin-dependent diabetes mellitus(IDDM) model.Islet transplantation was carried out to IDDM mice with sIL-1RI-Ig gene-modified islet cells.Then the survival time of grafts was tested by daily observing blood glucose and insulin levels.The expression of cytokines was detected in graft after transplantation by using RT-PCR. Pathological changes of the graft were also observed by chromoscopy with HE after transplantation.Results The survival time of the grafts in sIL-1RI-Ig-islet group (39±3 days) was prolonged significantly (P<0.01) as compared with controls.A down-regulation of cytokines expression was detected in grafts after transplantation.Less damage and infiltration of lymphocytes were found in sIL-1RI-Ig gene-transfected group.Conclusion The effects of islet cells modified with sIL-1RI-Ig before transplantation on the rejection of murine islet allograft were investigated.The results verified that sIL-1RI-Ig-modified islet allograft could prolong the survival of grafts significantly,and demonstrated it was possible that sIL-1RI-Ig preventedallograft rejection via reducing the expression of cytokines(TNF-α,IFN-γ,RANTES,etc.).
ABSTRACT
Kidney allograft transplantation is the most effective method of renal replacement for end stage renal disease patients. Still, it is another kind of 'disease', requiring immunosuppression to keep the allograft from rejection(allograft immune reaction). Immune system of the allograft recipient recognizes the graft as a 'pathogen(foreign or danger)', and the allograft-recognizing commander- in-chief of adaptive immune system, T cell, recruits all the components of immune system for attacking the graft. Proper activation and proliferation of T cell require signals from recognizing proper epitope(processed antigen by antigen presenting cell) via T cell receptor, costimulatory stimuli, and cytokines(IL-2). Thus, most of the immunosuppressive agents suppress the process of T cell activation and proliferation.